Avion Wealth’s Avanos Medical AVNS Stock Holding History

Avion Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	30	–	–	﹤0.01%	1432
2026 Q1	$0	Hold	30	–	–	﹤0.01%	1238
2025 Q4	$0	Hold	30	–	–	﹤0.01%	1224
2025 Q3	$0	Buy	+30	New	+$351	﹤0.01%	1192

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Avion Wealth's AVNS Position: Q2 2026 in Review

Avion Wealth held its Avanos Medical (AVNS) position steady in Q2 2026 at 30 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1432.

Avion Wealth first reported a position in AVNS in Q3 2025 and has held it in 4 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Avion Wealth held 30 shares of Avanos Medical worth $0 as of Q2 2026.
Avion Wealth left its Avanos Medical share count unchanged in Q2 2026.
Avanos Medical made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1432 holding.
Avion Wealth first reported a position in Avanos Medical in Q3 2025 and has held it in 4 quarters since.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.